ask="21.40"
ask_size="300"
average_daily_volume="53000"
bid="12.15"
bid_size="100"
book_value="3.15"
change="+0.28"
change_from_200_day_moving_average="2.64"
change_from_50_day_moving_average="0.78"
change_from_52_week_high="-0.51"
change_From_52_week_low="9.36"
change_in_percent="+1.31%"
close="21.28"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.72"
ebitda="-68.26M"
eps_estimate_current_year="-2.36"
eps_estimate_next_quarter="-0.58"
eps_estimate_next_year="-2.09"
ex_dividend_date="N/A"
float_shares="10188000"
high="21.29"
high_52_weeks="21.79"
last_trade_date="1/24/2017"
last_trade_price="21.28"
last_trade_size="139"
last_trade_time="4:00pm"
low="20.49"
low_52_weeks="11.92"
market_capitalization="536.45M"
moving_average_200_day="18.64"
moving_average_50_day="20.50"
name="Ascendis Pharma A/S - American "
notes="N/A"
one_year_target_price="29.67"
open="21.00"
pe_ratio="N/A"
peg_ratio="-0.37"
percent_change_from_200_day_moving_average="+14.16%"
percent_change_from_50_day_moving_average="+3.79%"
percent_change_from_52_week_high="-2.34%"
percent_change_from_52_week_low="+78.52%"
previous_close="21.00"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="6.68"
price_per_sales="89.67"
revenue="5.90M"
shares_outstanding="25209000"
short_ratio="8.24"
stock_exchange="NMS"
symbol="ASND"
volume="29956"
weeks_range_52="11.92 - 21.79"
